Browsing Category
COVID-19
The Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks
In light of the current novel coronavirus (COVID-19) pandemic as well as other viral outbreaks in the 21st century, there is a dire need for new diagnostic and therapeutic strategies to combat infectious diseases worldwide. As a convergence science, tissue engineering has traditionally focused on…
Read More...
Read More...
New Delivery Method Could Make Niclosamide an Effective Antiviral to Treat COVID-19
Repurposing drugs such as the FDA-approved niclosamide is a highly efficient way to leverage drugs with known safety profiles to fight the coronavirus outbreak. College of Pharmacy researchers at The University of Texas at Austin are now using new drug delivery formulation technologies to increase…
Read More...
Read More...
Excipact Procedure For Audit Postponement And Remote Audits
6th April 2020
In response to the COVID-19 pandemic and following the EXCIPACT position paper of 24 March 2020, this document sets out a new procedure for audit postponement and the use of remote audits for those pharmaceutical excipients suppliers who are already EXCiPACT certified.…
Read More...
Read More...
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational…
University of Pittsburgh School of Medicine scientists announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to…
Read More...
Read More...
Phospholipid-Based Delivery Systems – Advanced Vaccines in Modern Medicine
Vaccine Adjuvants
The routine use of vaccines is one of the most out- standing accomplishments of modern medicine. The first major milestone was the eradication of smallpox. Nowadays, emerging pathogens like Sars-CoV-2 require innovative vaccination approaches. Besides the prevention of infectious…
Read More...
Read More...
USP: Pandemic Preparedness for Regulators in Low- and Middle-Income Countries
The COVID19 pandemic is testing global medical supply chains. Read the new US Pharmacopeia paper on Pandemic Preparedness for Regulators in Low- and Middle-Income Countries. This is the first one in the new series on pandemic preparedness for regulators in LMICs, which frames how regulatory…
Read More...
Read More...